A New Generation of TMVR
Specifically Designed for
STREAMLINED TRANSSEPTAL DELIVERY

 
blue ring header tech.png
 

Broadens the Treatable Patient Population

  • Includes both primary and secondary mitral regurgitation patients who are high risk for open-heart surgery

  • Positioned above the native mitral valve, atrial-only fixation ensures critical cardiac structures are retained within the left ventricle

  • AltaValve was engineered to minimize complications sometimes found with other TMVR technologies such as device embolization, left ventricular outflow tract (LVOT) obstruction, left ventricular dysfunction (e.g. chordae tendineae rupture), etc.

  • AltaValve’s stent enables future left atrial access for other procedures

  • AltaValve is the only device designed to treat patients with previous valve repair

CAUTION -- Investigational device. Limited by Federal (or United States) law to investigational use.

 

Specifically Designed for Streamlined Transseptal Delivery

 
  • AltaValve is recapturable even after complete deployment, leading to improved procedural safety*

  • The prosthetic valve is fully functional seconds after deployment, ensuring patient’s hemodynamic stability

  • TS Delivery System provides controlled steerability, accommodating a variety of anatomies

 
 
*AltaValve is fully recapturable at any point in the procedure until it is detached from the delivery catheter

*AltaValve is fully recapturable at any point in the procedure until it is detached from the delivery catheter

 
 

Also Available in Transapical Delivery

 
*AltaValve is fully recapturable at any point in the procedure until it is detached from the delivery catheter